Edwards Lifesciences (EW) Misses Q2 EPS by 1c, Q3 Revenue Guidance Misses

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. SMCI
8. RTX
9. S
10. COF

Go back to Edwards Lifesciences (EW) Misses Q2 EPS by 1c, Q3 Revenue Guidance Misses

Edwards Lifesciences (EW) Down on Earnings Miss as Hospital Staffing 'Remains Uncertain'

July 29, 2022 1:32 PM EDT

Edwards Lifesciences (NYSE: EW) shares have fallen over 6% Friday on the back of its earnings release.

The company reported after the close Thursday, missing earnings and revenue expectations.

Edwards Lifesciences reported earnings of $0.63, $0.01 worse than the analyst estimate of $0.64 on revenue of $1.37 billion, missing the consensus estimate of $1.4 billion.

The company said it experienced persistent disruption within the healthcare... More